Trial intelligence / Profile preview

Opioid-free esketamine anesthesia vs opioid-based anesthesia in elderly thoracoscopic surgery

ChiCTR2400092239Phase 4Not yet recruiting

Sponsor
Liaoning Province Cancer Hospital
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in post-operative cognitive decline (POCD) (2 arms), sponsored by Liaoning Province Cancer Hospital. Primary endpoint: Postoperative cognitive function. Planned start Nov 2024; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

post-operative cognitive decline (POCD)

Beyond the preview

Go deeper on ChiCTR2400092239.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400092239.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call